The Anavex 2-73 Study
Do you or your loved one have Alzheimer’s Disease?
Are you interested in taking part in a clinical trial?
NeuroCentrix invites you to learn more about a clinical research study involving the use of a new investigational medication.
Who can take part?*
- Aged 60-85
- A diagnosis of early Alzheimer’s Disease
- Availability of a study partner who spends at least 10 hours per week with the participant
What to expect
- Study duration of approximately 48 weeks including 6 on-site visits
- Study-related care, medical and cognitive assessments and study medication every 3 months
*Please note that there are additional criteria that must be met in order to qualify to participate in this study.